Relapsed Synovial Sarcoma: Treatment Options.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 3, p. 229, doi. 10.1007/s11864-023-01056-5
- By:
- Publication type:
- Article
Works matching IS 15272729 AND DT 2023 AND VI 24 AND IP 3
Results: 6
1
2
A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 3, p. 212, doi. 10.1007/s11864-023-01054-7
- By:
- Publication type:
- Article
3
Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 3, p. 147, doi. 10.1007/s11864-023-01051-w
- By:
- Publication type:
- Article
4
Immunotherapy in HPV-Related Oropharyngeal Cancers.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 3, p. 170, doi. 10.1007/s11864-023-01050-x
- By:
- Publication type:
- Article
5
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 3, p. 184, doi. 10.1007/s11864-023-01049-4
- By:
- Publication type:
- Article
6
The Role of Induction Therapy for Sinonasal Cancers.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 3, p. 162, doi. 10.1007/s11864-022-01046-z
- By:
- Publication type:
- Article